ClinConnect ClinConnect Logo
Search / Trial NCT03838094

Evaluation of MTA Versus Biodentine as Pulpotomy Agents in Immature First Permanent Molars

Launched by GIHAN M ABUELNIEL ,PHD · Feb 8, 2019

Trial Information

Current as of May 29, 2025

Completed

Keywords

Pulp Exposure Vital Immature Mta Biodentine

ClinConnect Summary

Diagnosis:

1. Full history data will be collected, including personal, medical and previous dental data
2. Clinical examination using mirror and probe to assess the inclusion criteria.
3. Radiographic examination using preoperative digital periapical radiograph to assess the inclusion criteria.
4. Preoperative photograph will be taken.

Operative procedure:

Experimental group:

1. Injection of local anesthesia and rubber dam isolation.
2. caries and roof of the pulp chamber will be removed by a fissure diamond bur (Diatech, Heerbrug, Switzerland) and high-speed handpiece with coolant.
3. ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Bilaterally Symptomatic ⁄ asymptomatic vital immature mandibular first permanent molars (with clinical carious exposure of the pulp and presence of bleeding upon exposure)
  • Patients with an age range from 7-8 years.
  • Absence of sinus tract, soft tissue swelling.
  • Exclusion Criteria:
  • • Molars were excluded if non-restorable.
  • excessive mobility (more than 1 mm horizontally).
  • Radiographic evidence of peri- and ⁄or inter-radicular lesions, internal⁄ external root resorption, pulp⁄ canal calcifications.

About Gihan M Abuelniel ,Phd

Dr. Gihan M. Abuelniel, PhD, is a distinguished clinical trial sponsor with a robust background in biomedical research and a commitment to advancing medical science through innovative clinical studies. With expertise in trial design, regulatory compliance, and data analysis, Dr. Abuelniel leads initiatives that prioritize patient safety and efficacy in therapeutic interventions. Her collaborative approach fosters partnerships with healthcare professionals and research institutions, ensuring that each study is conducted with the highest ethical standards and scientific rigor. Driven by a passion for improving patient outcomes, Dr. Abuelniel is dedicated to translating research findings into tangible healthcare solutions.

Locations

Patients applied

0 patients applied

Trial Officials

Gihan M Abuelniel, PhD

Principal Investigator

Cairo University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials